systemic lupus erythematosus: An autoimmune multi-organ disease typically associated with vasculopathy and autoantibody production. Most patients have antinuclear antibodies (ANA). The presence of anti-dsDNA or anti-Smith antibodies are highly-specific.
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
M13_SLE
Extra metadata
List of similar endpoints to
Systemic lupus erythematosus
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 687 | 575 | 112 |
| Unadjusted prevalence (%) | 0.26 | 0.39 | 0.10 |
| Mean age at first event (years) | 45.66 | 44.93 | 49.38 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.05 | 3.80 [1.95, 7.40] | 8.5e-5 | 63 |
| 15 years | 0.03 | 4.60 [2.50, 8.46] | 9.6e-7 | 51 |
| 5 years | 0.01 | 7.61 [3.91, 14.82] | 2.4e-9 | 23 |
| 1 year | - | - | - | - |
Index endpoint: M13_SLE – Systemic lupus erythematosus
GWS hits: 3
before Systemic lupus erythematosus
after Systemic lupus erythematosus
Loading survival analyses plot
Loading survival analyses table